FGFR3 and breast neoplasm: High expression of fibroblast growth factor receptor 3 (FGFR3) is indicated in tamoxifen-resistant breast tumors by stimulating activation of the Ras/Raf/MEK1/2/ERK1/2 and PI3K/AKT/mTOR signaling pathways (91).